Prognostic value of circulating macrophage inhibitory cytokine 1-growth differentiation factor 15 (MIC-1/GDF15) in obesity: Relation with vascular endothelial growth factor (VEGF) and markers of oxidative stress
Restricted accessResearch articleFirst published online December, 2023
Prognostic value of circulating macrophage inhibitory cytokine 1-growth differentiation factor 15 (MIC-1/GDF15) in obesity: Relation with vascular endothelial growth factor (VEGF) and markers of oxidative stress
Background: Macrophage inhibitory cytokine 1-Growth differentiation Factor 15 (MIC-1/GDF15) and vascular endothelial growth factor (VEGF) are novel regulators of obesity and energy homeostasis and food intake. Aims: In the current cross-sectional study, we aimed to evaluate MIC-1 and VEGF concentrations and their association with serum lipids and biomarkers of oxidative stress in obese individuals. Methods: Fifty six obese subjects, aged between 20–50 years old, participated in the current study. Anthropometric and nutritional parameters were assessed and serum and blood concentrations of MIC-1/GDF15, VEGF, markers of oxidative stress and serum lipids were evaluated. Results: Serum VEGF was strongly associated with serum lipids and MIC-1/GDF15 concentrations while serum MIC-1/GDF15 was associated with total cholesterol (TC) and VEGF levels. In multivariate regression analysis, serum VEGF, appetite and GPX were potent determinants of MIC-1/GDF15 concentrations while VEGF was only associated with serum MIC-1/GDF15. Conclusion: The findings of the current study demonstrated the association between MIC-1/GDF15 and VEGF. Moreover, a positive association between these cytokines and serum lipids, was also observed. The results suggest that MIC-1/GDF15 and VEGF might be considered as prognostic markers in obesity-related metabolic disorders. Although further mechanistic studies are needed to better clarify the underlying mechanism.
AdolphTEGrabherrFMayrL, et al. (2018) Weight loss induced by bariatric surgery restricts hepatic GDF15 expression. Journal of Obesity2018: 1–6.
2.
BauskinARBrownDAKuffnerT, et al. (2006) Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer. Cancer Research66(10): 4983–4986.
3.
CaiLLiCWangY, et al. (2021) Increased serum GDF15 related to improvement in metabolism by lifestyle intervention among young overweight and obese adults. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy14: 1195–1202.
4.
ChengFZhaoLWuY, et al. (2016) Serum vascular endothelial growth factor B is elevated in women with polycystic ovary syndrome and can be decreased with metformin treatment. Clinical Endocrinology84(3): 386–393.
5.
ChuengsamarnSRattanamongkolgulSPhonratB, et al. (2014) Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: A randomized controlled trial. The Journal of Nutritional Biochemistry25(2): 144–150.
6.
DingQMracekTGonzalez-MuniesaP, et al. (2009) Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes. Endocrinology150(4): 1688–1696.
7.
DostálováIRoubicekTBártlováM, et al. (2009) Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: The influence of very low calorie diet. European Journal of Endocrinology161(3): 397–404.
8.
FarhangiMAKeshavarzSAEshraghianM, et al. (2013) Vitamin A supplementation, serum lipids, liver enzymes and C-reactive protein concentrations in obese women of reproductive age. Annals of Clinical Biochemistry50(1): 25–30.
9.
GodeSAksuTDemirelA, et al. (2016) Effect of vitamin D deficiency on the development of postoperative atrial fibrillation in coronary artery bypass patients. Journal of Cardiovascular and Thoracic Research8(4): 140–146.
10.
Gómez-AmbrosiJCatalánVRodríguezA, et al. (2010) Involvement of serum vascular endothelial growth factor family members in the development of obesity in mice and humans. Journal of Nutritional Biochemistry21(8): 774–780.
11.
HagbergCEFalkevallAWangX, et al. (2010) Vascular endothelial growth factor B controls endothelial fatty acid uptake. Nature464(7290): 917–921.
12.
HajiluianGAbbasalizad FarhangiMJahangiryL (2017) Mediterranean Dietary pattern and VEGF+405 G/C gene polymorphisms in patients with metabolic syndrome: an aspect of gene-nutrient interaction. PloS one12(2): e0171637.
13.
HardemanWGriffinSJohnstonM, et al. (2000) Interventions to prevent weight gain: A systematic review of psychological models and behaviour change methods. International Journal of Obesity24(2): 131–143.
14.
HuhSJChungCYSharmaA, et al. (2010) Macrophage inhibitory cytokine-1 regulates melanoma vascular development. American Journal of Pathology176(6): 2948–2957.
15.
JohnenHLinSKuffnerT, et al. (2007) Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1. Nature Med13(11): 1333–1340.
16.
KelishadiRArdalanGGheiratmandR, et al. (2007) Association of physical activity and dietary behaviours in relation to the body mass index in a national sample of Iranian children and adolescents: CASPIAN study. Bulletin World Health Organization85(1): 19–26.
17.
KempfTGuba-QuintATorgersonJ, et al. (2012) Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: Results from the XENDOS trial. Europ J Endocrinol167(5): 671–678.
18.
KhatibiFKYaghoubiAZarghamiN, et al. (2013) Evaluation of hs-CRP, antioxidant markers and MDA in patients of coronary artery disease (CAD) containing non-smokers and non-diabetics. Journal of Cardiovascular and Thoracic Research2(4): 13–18.
19.
KimGWChoBDLeeHS, et al. (2003) Comparison analysis of an indirect measurement of friedwal formula method and direct measurment of immunoseparation method on low-density lipoprotein cholesterol measurement. Korean Journal of Medicine64(1): 41–48.
20.
KimKKLeeJJYangY, et al. (2008) Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells. Carcinogenesis29(4): 704–712.
21.
KredelLISiegmundB (2014) Adipose-tissue and intestinal inflammation–visceral obesity and creeping fat. Frontiers in Immunology5: 62.
22.
LemoineAYLedouxSLargerE (2013) Adipose tissue angiogenesis in obesity. Thrombosis Haemostasis110(10): 661–669.
23.
MakeyKLPattersonSGRobinsonJ, et al. (2013) Increased plasma levels of soluble vascular endothelial growth factor (VEGF) receptor 1 (sFlt-1) in women by moderate exercise and increased plasma levels of VEGF in overweight/obese women. European Journal of Cancer Prevention22(1): 83–89.
24.
MartinSSQasimAReillyMP (2008) Leptin resistance: A possible interface of inflammation and metabolism in obesity-related cardiovascular disease. Journal of the American College of Cardiology52(15): 1201–1210.
25.
MickGJWangXMcCormickK (2002) White adipocyte vascular endothelial growth factor: Regulation by insulin. Endocrinology143(3): 948–953.
26.
Miyazawa-HoshimotoSTakahashiKBujoH, et al. (2003) Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects. Diabetologia46(11): 1483–1488.
27.
MyersMGCowleyMAMünzbergH (2008) Mechanisms of leptin action and leptin resistance. Annual Review of Physiology70(1): 537–556.
PezeshkianMDarbinARashidiMR, et al. (2011) The effect of atherogenic diet with or without enzyme inhibitors on the incidence and progress of atherosclerosis in rabbits. Journal of Cardiovascular and Thoracic Research3(1): 7–10.
30.
PiyaMKHarteALMcTernanPG (2013) Metabolic endotoxaemia: Is it more than just a gut feeling?Current Opinion in Lipidology24(1): 78–85.
31.
RiazyMChenJHSteinbrecherUP (2009) VEGF Secretion by macrophages is stimulated by lipid and protein components of OxLDL via PI3-kinase and PKCζ activation and is independent of OxLDL uptake. Atherosclerosis204(1): 47–54.
32.
SchäferGCramerTSuskeG, et al. (2003) Oxidative stress regulates vascular endothelial growth factor-A gene transcription through Sp1-and Sp3-dependent activation of two proximal GC-rich promoter elements. Journal of Biological Chemistry278(10): 8190–8198.
33.
SharifiMHEftekhariMHOstovanMA, et al. (2017) Effects of a therapeutic lifestyle change diet and supplementation with Q10 plus L-carnitine on quality of life in patients with myocardial infarction: A randomized clinical trial. Journal of Cardiovascular and Thoracic Research9(1): 21–28.
34.
SilvaSAGobboMGPinto-FochiME, et al. (2015) Prostate hyperplasia caused by long-term obesity is characterized by high deposition of extracellular matrix and increased content of MMP-9 and VEGF. International Journal of Experimental Pathology96(1): 21–30.
35.
SmeetsAJWesterterp-PlantengaMS (2008) Acute effects on metabolism and appetite profile of one meal difference in the lower range of meal frequency. British Journal of Nutrition99(6): 1316–1321.
36.
SokhanvarSRohiSMRMousavinasabN, et al. (2011) The association between serum lipoprotein (a) and other cardiac risk factors with the severity of coronary artery disease. Journal of Cardiovascular and Thoracic Research3(1): 35–39.
37.
TrapeJMoralesCMolinaR, et al. (2006) Vascular endothelial growth factor serum concentrations in hypercholesterolemic patients. Scandinavian Journal of Clinical and Laboratory Investigation66(3): 261–267.
38.
TsaiVWMaciaLJohnenH, et al. (2013) TGF-b superfamily cytokine MIC-1/GDF15 is a physiological appetite and body weight regulator. PloS one8(2): e55174.
39.
XiongYWalkerKMinX, et al. (2017) Long-acting MIC-1/GDF15 molecules to treat obesity: evidence from mice to monkeys. Science Translational Medicine9(412): eaan8732.
40.
ZeinalianRFarhangiMAShariatA, et al. (2017) The effects of spirulina Platensis on anthropometric indices, appetite, lipid profile and serum vascular endothelial growth factor (VEGF) in obese individuals: A randomized double blinded placebo controlled trial. BMC Complementary and Alternative Medicine17(1): 225–230.
